Redsense Medical AB (publ) (XSAT:REDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.390
+0.090 (2.73%)
At close: Mar 18, 2026

Redsense Medical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.3615.366.973.674.98
Short-Term Investments
---6.9121.97
Cash & Short-Term Investments
7.3615.366.9710.5826.95
Cash Growth
-52.10%120.44%-34.16%-60.74%-58.55%
Accounts Receivable
6.256.12.974.933.53
Other Receivables
0.390.411.760.330.67
Receivables
6.636.514.725.264.2
Inventory
8.75.991.361.531.38
Prepaid Expenses
0.580.140.20.640.41
Other Current Assets
0----
Total Current Assets
23.2827.9913.2418.0132.94
Property, Plant & Equipment
0.270.310.360.370.37
Long-Term Deferred Charges
15.7213.512.9112.359.94
Other Long-Term Assets
0-0-0-
Total Assets
39.2641.826.5130.7343.25
Accounts Payable
1.990.521.750.981.33
Accrued Expenses
2.871.231.362.140.84
Other Current Liabilities
0.120.460.310.471.02
Total Current Liabilities
4.982.213.413.583.19
Long-Term Debt
----2.57
Other Long-Term Liabilities
-0---
Total Liabilities
4.982.213.413.585.76
Common Stock
1.641.641.41.41.4
Additional Paid-In Capital
----123.63
Retained Earnings
32.6437.9421.6925.75-87.54
Comprehensive Income & Other
00--0
Shareholders' Equity
34.2839.5923.127.1537.49
Total Liabilities & Equity
39.2641.826.5130.7343.25
Total Debt
----2.57
Net Cash (Debt)
7.3615.366.9710.5824.38
Net Cash Growth
-52.10%120.44%-34.16%-56.60%-62.51%
Net Cash Per Share
0.450.900.490.751.74
Filing Date Shares Outstanding
16.4416.4414.0414.0414.04
Total Common Shares Outstanding
16.4416.4414.0414.0414.04
Working Capital
18.325.789.8314.4329.75
Book Value Per Share
2.082.411.641.932.67
Tangible Book Value
34.2839.5923.127.1537.49
Tangible Book Value Per Share
2.082.411.641.932.67
Machinery
-0.550.530.480.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.